{
  "ticker": "LLY",
  "target_date": "2025-09-02",
  "actual_date": "2025-09-02",
  "collected_at": "2025-12-08T12:13:38.249744",
  "price": {
    "open": 726.92,
    "high": 736.06,
    "low": 722.58,
    "close": 734.1118774414062,
    "volume": 3222500,
    "change_1d_pct": 0.36,
    "change_7d_pct": 3.57,
    "change_30d_pct": -3.33
  },
  "technicals": {
    "rsi_14": 83.65,
    "sma_20": 698.04,
    "sma_50": 745.51,
    "macd": -3.093,
    "macd_signal": -11.269,
    "macd_histogram": 8.176,
    "bb_upper": 779.72,
    "bb_lower": 616.35,
    "price_vs_sma20_pct": 5.17,
    "price_vs_sma50_pct": -1.53,
    "volume_ratio": 0.48
  },
  "fundamentals": {
    "market_cap": 892288237568,
    "pe_ratio": 48.76776,
    "forward_pe": 43.92542,
    "price_to_book": 37.47553,
    "price_to_sales": 15.016682,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.49,
    "pct_from_52w_low": 59.57
  },
  "macro": {
    "spy": {
      "price": 638.5,
      "change_1d_pct": -0.74,
      "change_7d_pct": -0.78
    },
    "vix": {
      "level": 17.17,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.28
    },
    "dollar_index": {
      "level": 98.4
    },
    "gold": {
      "price": 3549.4
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "More Ways to Cut Cholesterol, Triglycerides Are Coming. This Stock Took Off.",
      "source": "Yahoo",
      "datetime": 1756854000,
      "summary": "A triglyceride-cutting drug from  Ionis Pharmaceuticals  proved so effective in a trial reported this past weekend that the biotech\u2019s shares jumped more than 30%.  Other news at the European Society of Cardiology Congress featured an  AstraZeneca  pill that the company thinks will become the best tr",
      "url": "https://finnhub.io/api/news?id=5bbb3bde79059b661fd16293170b24d210d814a41e6a015fef794889822003c2"
    },
    {
      "headline": "Stocks to Watch Recap: Alphabet, Nvidia, Comerica, Constellation Brands",
      "source": "Yahoo",
      "datetime": 1756849748,
      "summary": "\u2197\ufe0fAlphabet (GOOGL): The Google parent's stock rose 8% postmarket after a federal judge issued remedies in a monopoly case that were initially viewed as manageable for the search giant. Apple (AAPL) shares also advanced 3%.",
      "url": "https://finnhub.io/api/news?id=a252163d16f7b4eee573a937e6f44f3b05f91b8fe355da00647518dabb8a19d1"
    },
    {
      "headline": "Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q2 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1756849047,
      "summary": "Duquesne Family Office's Q2 2025 portfolio updates: key bets in tech & healthcare, new positions, and Druckenmiller's trend-driven investment strategy. See more.",
      "url": "https://finnhub.io/api/news?id=315d9f22e7d3c057f52bab7338e438e39f181b472233cbb7ba0439567411a854"
    },
    {
      "headline": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know",
      "source": "Yahoo",
      "datetime": 1756848333,
      "summary": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=ad09a8413baa44cd27959f8443efc0ef480afeac7d01b47cbb5ff386a335eb85"
    },
    {
      "headline": "These 3 Companies are Seeing Supercharged Sales Growth",
      "source": "Yahoo",
      "datetime": 1756830600,
      "summary": "The 2025 Q2 earnings season is now behind us, with the period largely positive and resilient. Throughout the period, these three companies posted notably strong sales growth.",
      "url": "https://finnhub.io/api/news?id=3c80d5c28410dcb362268d017d9cb0b9b2d7541dd8be7ad104aa68a0dd1f731c"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-08-28",
      "description": "xslF345X05/wk-form4_1756412129.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000236/xslF345X05/wk-form4_1756412129.xml"
    },
    {
      "form": "4",
      "date": "2025-08-28",
      "description": "xslF345X05/wk-form4_1756412046.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000234/xslF345X05/wk-form4_1756412046.xml"
    },
    {
      "form": "8-K",
      "date": "2025-08-20",
      "description": "d929636d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312525184093/d929636d8k.htm"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634987.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000232/xslF345X05/wk-form4_1755634987.xml"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634943.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000230/xslF345X05/wk-form4_1755634943.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}